Oshida T, Taniguchi T. Total intravenous anaesthesia with remimazolam in a patient with progressive supranuclear palsy.
Anaesth Rep 2025;
13:e70011. [PMID:
40342908 PMCID:
PMC12058351 DOI:
10.1002/anr3.70011]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/25/2025] [Indexed: 05/11/2025] Open
Abstract
Progressive supranuclear palsy is a neurodegenerative disease of unknown aetiology; few reports address its anaesthetic management. Remimazolam, a recently approved short-acting benzodiazepine, was used in combination with remifentanil for total intravenous anaesthesia during open cholecystectomy in a patient with progressive supranuclear palsy. Due to its cardiovascular stable profile and rapid reversibility with flumazenil, remimazolam may serve as a viable option for general anaesthesia in patients with this condition.
Collapse